Page 46 - Read Online
P. 46

Chen et al. Hepatoma Res 2018;4:4  I  http://dx.doi.org/10.20517/2394-5079.2017.50                                                  Page 5 of 10

                                           Table 1. Key variables of structure questionnaires
                              Baseline questionnaires (1998)  Updated questionnaires (2012)
                              Unique code                   Occupation
                              Name                          Family size
                              Gender                        Family income
                              ID code (containing birth date and gender)  Temporary place
                              Occupation                    Staple food
                              Home address                  Drinking water
                              Employer                      Alcohol drinking
                              Phone call                    Tea drinking
                              Birth place                   Smoking
                              Education                     Medical history
                              Marital status                Family history of cancer
                              Financial condition           Family history of HCC
                              Staple food                   Diabetes history
                              Drinking water                High blood pressure history
                              Tobacco consumption
                              Alcohol drinking
                              Tea drinking
                              Medical history
                              Menstrual and reproductive history (if female)
                              Vaccination history
                              Prophylactic intervention
                                                  HCC: hepatocellular carcinoma

               antibody to hepatitis B surface antigen, hepatitis B e antigen, antibody to hepatitis B e antigen, and antibody to
               hepatitis B core antigen, as well as urine glucose, and fasting blood glucose were also measured. In particular,
               baseline HBV DNA load, a well acknowledged viral parameter, was surveyed by using cryopreserved plasma
               samples between 2014 and 2015.


               Other parameters based on nested case-control design
               Several nested case-control studies have been carried out by using samples collected in the QBC. Exposure
               biomarkers and genetic variation markers measured were determined for some of the study participants,
               including aflatoxin metabolism , aflatoxin-albumin adducts , polymorphism of Glutathione S-Transferase
                                         [10]
                                                                  [11]
                                                                          [14]
                                          [13]
               T1 and M1 , epoxide hydrolase , xeroderma pigmentosum group D , codon 249 mutation of p53, loss of
                        [12]
               heterozygosity at chromosome 4q , HBV genotype and versatile HBV mutations in X gene [16-20] , S gene , C
                                           [15]
                                                                                                      [21]
               gene [22,23] , and P gene [24-27]  of HBV genome.
               WHAT HAS BEEN FOUND?
               HBV infection and PLC endemic in Qidong
               By the end of February 2017, after a median follow-up duration of 24.83 years, a total of 201 incident PLC cases
               were identified in the QBC. PLC was the most common cancer type, comprising more than 65% (201/304) of
               all cancer cases. PLC incidence in the HBV exposed sub-cohort was significantly higher than that of the HBV non-
               exposed sub-cohort with an incidence rate ratio (IRR) of 12.32 (95% CI: 7.16-21.21, P < 0.0001). No other statistically
               significant IRR were observed on any other cancers including lung, gastric, colorectal etc. [Table 2]. These findings,
               in addition to our previous publications on the QBC, define HBV infection as the most important etiologic
               factor for explaining the PLC epidemic in Qidong [28-30] .

               Furthermore, we have explored the association between HBeAg status, HBV DNA load and PLC risk in the
               HBV exposed sub-cohort. We found that the relative risk of PLC was 13.25 (95% CI: 6.67-26.33, P < 0.0001)
                                                                                                   +
                                                                +
                                                                       -
               and 28.05 (95% CI: 13.87-56.73, P < 0.0001) in the HBsAg /HBeAg  group and the HBsAg / HBeAg  group,
                                                                                           +
               respectively, as compared to the HBsAg /HBeAg  group [31,32] . Those with levels of HBV DNA more than 250
                                                 -
                                                        -
               copies/mL had a 4.78-fold risk of PLC compared to those without detectable HBV DNA. The HBsAg carriers
               with serum HBV DNA between 10  and 10  copies/mL had the greatest PLC risk, that is to say, greater than
                                             5
                                                   6
   41   42   43   44   45   46   47   48   49   50   51